Axon stock lagged the broader market after a planned CEO sale. [1] Zacks filed the Wednesday hangover. [1] This paper printed the sale ease Tuesday. A ticker is not a verdict. Silence from a court is not a win. Print lagging. Do not print a judgment.

Duo's $1,999 SKU is a different tape. Leave a named Axon order to the edition that owns an order. Tuesday's ad-hoc file named the sale and the hangover. Wednesday does not convert a candle into a court. A quiet ticker is not an Axon judgment. Silence from a regulator is not a win. A hangover is not a docket. Print lagging, not a verdict.

Print not the judge. Wednesday is not an Axon verdict.

CEO sales after strong quarters are calendar events, not outlook changes. Tuesday's ad-hoc file named both halves. Wednesday's candle extends the hangover, not the docket.

Ad-hoc filings name the sale and the quarter in one breath. Wednesday reads both halves together. The hangover is priced in.

Priced hangovers stay priced; Wednesday's candle is not a docket. Calendar sales after strong quarters. Not a verdict.

Wednesday reads both halves together. The hangover is priced in. Not a verdict.

Zacks filed Axon's Wednesday hangover after Tuesday named a CEO sale. The candle lagged the market, not a courtroom win. No regulator converted that candle into a docket. Foldable pricing lives on another ticker entirely.
Priced in. Not a verdict. The hangover is a candle, not a courtroom.

Foldable pricing lives on another ticker entirely. No docket absorbed Wednesday's hangover. Wednesday's hangover is a candle.

Wednesday's Axon hangover is a candle, not a courtroom. No docket absorbed Wednesday's hangover. Foldable pricing lives on another ticker.

-- THEO KAPLAN, San Francisco